Preferred Label : Diroximel Fumarate;

UNII : K0N0Z40J3W;

InChIKey : YIMYDTCOUQIDMT-SNAWJCMRSA-N;

CAS number : 1577222-14-0;

NCI Metathesaurus CUI : CL1382413;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/vumerity
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Diroximel Fumarate
Diroximel Fumarate
diroximel fumarate
multiple sclerosis, relapsing-remitting
adult
drug approval
europe
administration, oral
pregnancy
breast feeding
drug interactions
aged
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3322980/fr/vumerity-diroximel
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
multiple sclerosis, relapsing-remitting
diroximel fumarate
Diroximel Fumarate
Diroximel Fumarate
evaluation of the transparency committee

---
Nous contacter.
07/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.